|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Amlodipine#Adult Indications and Dosage]] |
| {{Amlodipine}}
| |
| {{CMG}}; {{AE}} {{AK}}
| |
| | |
| == Indications and Usage==
| |
| | |
| === Hypertension===
| |
| | |
| NORVASC® is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.
| |
| | |
| === Coronary Artery Disease (CAD)===
| |
| | |
| '''Chronic Stable Angina'''
| |
| NORVASC is indicated for the symptomatic treatment of [[chronic stable angina]]. NORVASC may be used alone or in combination with other [[antianginal]] agents.
| |
| | |
| '''Vasospastic Angina (Prinzmetal's or Variant Angina)'''
| |
| NORVASC is indicated for the treatment of confirmed or suspected [[vasospastic angina]]. NORVASC may be used as monotherapy or in combination with other antianginal agents.
| |
| | |
| '''Angiographically Documented CAD'''
| |
| In patients with recently documented [[CAD]] by [[angiography]] and without heart failure or an [[ejection fraction]] <40%, NORVASC is indicated to reduce the risk of hospitalization due to angina and to reduce the risk of a coronary [[revascularization]] procedure.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = NORVASC (AMLODIPINE BESYLATE) TABLET [CARDINAL HEALTH] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=44e5ad27-e062-461a-bdf4-192d852fbc49#nlm42230-3 | publisher = | date = | accessdate = 6 March 2014 }}</ref>
| |
| | |
| | |
| | |
| | |
| ==References==
| |
| | |
| {{Reflist|2}}
| |
|
| |
|
| [[Category:Cardiovascular Drugs]] | | [[Category:Cardiovascular Drugs]] |
| [[Category:Drugs]] | | [[Category:Drugs]] |